Live from the NIH registry
Studies recruiting near Elkhart right now
Top 25 of 105 recruiting studies, sorted by proximity — each links to its official registry page
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Breast Cancer, TNBC - Triple-Negative Breast Cancer
N/A
Observational 900 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: Tempus AI
Family Spirit Strengths
Depressive Symptoms, Anxiety Disorders and Symptoms
N/A
Interventional 188 participants sought
Pokagon Health Services — Pokagon, Michigan (18.8 mi)
· Sponsor: Johns Hopkins Bloomberg School of Public Health
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
Beacon Children's Hospital — South Bend, Indiana (14.8 mi)
· Sponsor: Children's Hospital of Philadelphia
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Midwest Cardiovascu Rsrch Foundation — Elkhart, Indiana (1.0 mi)
· Sponsor: Novo Nordisk A/S
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Digestive Research Alliance of Michiana — South Bend, Indiana (14.8 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — South Bend, Indiana (14.8 mi)
· Sponsor: Akero Therapeutics, Inc
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity
Phase 2
Interventional 338 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi)
· Sponsor: OHB Neonatology Ltd.
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Lakeland Hospital Niles — Niles, Michigan (17.8 mi)
· Sponsor: SWOG Cancer Research Network
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Elkhart General Hospital — Elkhart, Indiana (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Midwest Cardiovascular Research and Education Foundation — Elkhart, Indiana (1.0 mi)
· Sponsor: Boehringer Ingelheim
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: Children's Oncology Group
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Pancreatic Neoplasm
N/A
Observational 770 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: SWOG Cancer Research Network
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — South Bend, Indiana (14.8 mi)
· Sponsor: Alnylam Pharmaceuticals
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: NRG Oncology
Restorative Effects of Sleep on Everyday Health and Wellbeing: A Treatment Study
Chronic Insomnia
N/A
Interventional 115 participants sought
University of Notre Dame — Notre Dame, Indiana (14.2 mi)
· Sponsor: University of Notre Dame
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 700 participants sought
Indiana University — Goshen, Indiana (10.0 mi)
· Sponsor: Janssen Research & Development, LLC
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: Children's Oncology Group
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — South Bend, Indiana (14.8 mi)
· Sponsor: 89bio, Inc.
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)